Search Results - "BAGGOTT, M. J"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Mechanisms and Genetics of Antipsychotic-Associated Weight Gain by Balt, SL, Galloway, GP, Baggott, MJ, Schwartz, Z, Mendelson, J

    Published in Clinical pharmacology and therapeutics (01-07-2011)
    “…Antipsychotic medications, which comprise one of the most widely prescribed medication classes, have proven effective in many psychiatric conditions. However,…”
    Get full text
    Journal Article
  2. 2

    A Randomized, Placebo-Controlled Trial of Sustained-Release Dextroamphetamine for Treatment of Methamphetamine Addiction by Galloway, GP, Buscemi, R, Coyle, JR, Flower, K, Siegrist, JD, Fiske, LA, Baggott, MJ, Li, L, Polcin, D, Chen, CYA, Mendelson, J

    Published in Clinical pharmacology and therapeutics (01-02-2011)
    “…Sixty treatment‐seeking individuals with methamphetamine (MA) dependence entered a randomized, placebo‐controlled, double‐blind clinical trial of oral…”
    Get full text
    Journal Article
  3. 3

    Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire by Baggott, M.J, Coyle, J.R, Erowid, E, Erowid, F, Robertson, L.C

    Published in Drug and alcohol dependence (01-03-2011)
    “…Abstract Despite longstanding reports of prolonged or reoccurring perceptual changes in a subset of hallucinogen users, very little is known about Hallucinogen…”
    Get full text
    Journal Article
  4. 4

    Efficacy, Safety, and Ethics of Cosmetic Neurology Far From Settled by Flower, K, Li, L, Chen, C‐Y A, Baggott, M J, Galloway, G P, Mendelson, J

    Published in Clinical pharmacology and therapeutics (01-10-2010)
    “…In this issue, Larriviere and colleagues discuss the emerging use of drugs to enhance cognitive function. Several cautions they raise warrant amplification…”
    Get full text
    Journal Article
  5. 5

    Ketamine is associated with lower urinary tract signs and symptoms by Pal, R, Balt, S, Erowid, E, Erowid, F, Baggott, M.J, Mendelson, J, Galloway, G.P

    Published in Drug and alcohol dependence (01-09-2013)
    “…Abstract Background Case reports and series indicate that ketamine, an anesthetic agent, causes lower urinary tract symptoms (LUTS). This study explored…”
    Get full text
    Journal Article
  6. 6

    Buprenorphine and naloxone interactions in opiate-dependent volunteers by Mendelson, J, Jones, R T, Fernandez, I, Welm, S, Melby, A K, Baggott, M J

    Published in Clinical pharmacology and therapeutics (01-07-1996)
    “…Sublingual buprenorphine appears useful in the treatment of opiate dependence. A combination sublingual dose of buprenorphine and naloxone could have less…”
    Get more information
    Journal Article
  7. 7

    Use patterns and self-reported effects of Salvia divinorum: An internet-based survey by Baggott, Matthew J, Erowid, Earth, Erowid, Fire, Galloway, Gantt P, Mendelson, John

    Published in Drug and alcohol dependence (01-10-2010)
    “…Abstract Background There is growing use of Salvia divinorum (SD), a psychoactive plant that produces hallucinogen-like effects through a kappa opioid receptor…”
    Get full text
    Journal Article
  8. 8

    Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire by Baggott, M J, Coyle, J R, Erowid, E, Erowid, F, Robertson, L C

    Published in Drug and alcohol dependence (01-03-2011)
    “…Despite longstanding reports of prolonged or reoccurring perceptual changes in a subset of hallucinogen users, very little is known about Hallucinogen…”
    Get full text
    Journal Article
  9. 9

    A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task by Richards, J B, Baggott, M J, Sabol, K E, Seiden, L S

    Published in Brain research (12-11-1993)
    “…Rats were treated with a high-dose methamphetamine (METH) regimen (50 mg/kg 3 times at 8-h intervals). Three weeks after treatment, they were trained on a…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Use of salvia divinorum, an unscheduled hallucinogenic plant: a web-based survey of 500 users by Baggott, M. J., Erowid, E., Erowid, F., Mendelson, J. E.

    Published in Clinical pharmacology and therapeutics (01-02-2004)
    “…Salvia divinorum (SD) is a legal psychoactive plant that produces hallucinogen‐like effects through a putative kappa opiate mechanism. We characterized the…”
    Get full text
    Journal Article
  13. 13

    Preventing Problems in Ecstasy Users: Reduce Use to Reduce Harm by Baggott, Matthew J.

    Published in Journal of psychoactive drugs (01-04-2002)
    “…Increasing use of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been accompanied by concern about acute and possible long-term toxicity. This article…”
    Get full text
    Journal Article
  14. 14

    Doubling up by Baggott, Matthew J

    Published in New scientist (1971) (01-06-2002)
    “…A letter to the editor commends "New Scientist" for its review of discrepancies in the politicized field of Ecstasy research…”
    Get full text
    Magazine Article